Roclanda

latanoprost; netarsudil mesilate · Santen Oy

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Roclanda, covering 2026-03-24 to 2026-03-24. Get the full timeline:

Most recent: EMA Authorised: Roclanda (Latanoprost;netarsudil mesilate) — Santen Oy